American Diabetes Association
SUPPLEMENTARY_MATERIAL_12oct2020_Clean.pdf (272.12 kB)

Adaptation of Insulin Clearance to Metabolic Demand is a Key Determinant of Glucose Tolerance

Download (272.12 kB)
posted on 2020-10-19, 15:03 authored by Ada AdminAda Admin, Amalia Gastaldelli, Muhammad Abdul Ghani, Ralph A. DeFronzo
With the development of insulin resistance (IR), there is a compensatory increase in the plasma insulin response to offset the defect in insulin action in order to maintain normal glucose tolerance. The insulin response is the result of two factors: insulin secretion and metabolic clearance rate of insulin (MCRI).

T2DM subjects (104 NGT, 57 IGT, and 207), divided in non-obese and obese groups, received a euglycemic insulin-clamp (40 mU/m2.min) and OGTT (75-grams) on separate days. MCRI was calculated during the insulin-clamp performed with 3-3H-glucose and the OGTT and related to IR: peripheral (glucose uptake during insulin clamp), hepatic (basal EGPxFPI), and adipocyte (fasting FFAxFPI).

MCRI during the insulin-clamp was reduced in obese versus non-obese NGT (0.60±0.03 vs 0.73±0.02 L/min.m2, p<0.001), in non-obese IGT (0.62±0.02, p<0.004) and in non-obese T2DM (0.68±0.02, p<0.03). The MCRI during the insulin-clamp was strongly and inversely correlated with IR (r=-0.52, p<0.0001). During OGTT the MCRI suppressed within 15-30 minutes in NGT and IGT subjects and remained suppressed. In contrast, there was minimal suppression in T2DM.

In conclusion, the development of IR in obese subjects is associated with decline in MCRI that represents a compensatory response to maintain normal glucose tolerance but is impaired in T2DM individuals.


This study was supported in part by NIH grant DK24092 (RAD) and internal funds of the National Research Council, project MEDIFENCE (“MEtabolic DIseases, Food and ENvironment: from CElls to humans”) grant number DSB.AD003.061


Usage metrics



    Ref. manager